Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bovine coronavirus commonly found in calf respiratory screenings
There may be a link between respiratory infection and intestinal infection.
MSD says coronavirus needs to be taken seriously by vets and cattle industry.

Bovine coronavirus (BCoV) has become the most common virus found in routine screenings conducted during calf respiratory disease outbreaks, UK studies have shown.

Calf serology on 59 UK farms with history of respiratory disease issues between 2021 and 2022 revealed that 91.5 per cent of samples were positive for BCoV.

Calf respiratory disease is considered to be widespread, and has been highlighted as a critical area for overuse of antibiotics. MSD Animal Health say that there is an under use of vaccination in the UK cattle sector.

There are also concerns that there may be a link between respiratory infection and intestinal infection, as the virus is produced in the respiratory tract and then swallowed with excess mucus generated by the infection.

Speaking at the National Youngstock Conference, Dr Kat Baxter-Smith from MSD Animal Health UK called for veterinary practitioners and the UK cattle industry to take bovine coronavirus more seriously, just as human health experts changed their mindset during the Covid-19 pandemic.

Dr Baxter-Smith said: “While BCoV is a relatively well-known cause of neonatal calf diarrhoea – and the same virus as the respiratory variant – its role and impact in calf pneumonia has been less well defined. However, our latest diagnostic data certainly shows its overwhelming presence during calf respiratory disease outbreaks in the UK”

She added that BCoV is frequently isolated against other respiratory disease pathogens, such as BRSV, M. haemolytica, Pi3 and M. bovis, which may suggest interplay between the organisms.

Dr Baxter-Smith continued: “Research has already shown that BCoV infection disturbs the protective mucus lining of the thoracic tract. It may therefore be that BCoV ‘open the doors’ for the other viral and bacterial pathogens to establish themselves and cause disease.

“Whilst the pathogenicity of BCoV within the BRD complex remains an unknown quantity, its ubiquitous presence in the UK cattle population – and the recent human experience of coronavirus as a significant respiratory pathogen – suggests the need for some re-evaluation.”

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.